End-of-day quote
INDONESIA S.E.
18:00:00 2024-07-15 EDT
|
5-day change
|
1st Jan Change
|
1,000
IDR
|
0.00%
|
|
+0.50%
|
-23.37%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
945,047
|
937,364
|
750,436
|
1,095,025
|
2,161,243
|
2,029,081
|
Enterprise Value (EV)
1 |
3,361,016
|
3,028,171
|
2,328,190
|
2,342,357
|
3,291,559
|
2,680,355
|
P/E ratio
|
4.68
x
|
5.19
x
|
10
x
|
3.93
x
|
6.73
x
|
12.6
x
|
Yield
|
-
|
5.74%
|
3.06%
|
9.79%
|
5.4%
|
-
|
Capitalization / Revenue
|
0.13
x
|
0.14
x
|
0.13
x
|
0.17
x
|
0.27
x
|
0.28
x
|
EV / Revenue
|
0.47
x
|
0.46
x
|
0.42
x
|
0.35
x
|
0.42
x
|
0.37
x
|
EV / EBITDA
|
5.36
x
|
5.25
x
|
4.27
x
|
3.43
x
|
4.46
x
|
5.47
x
|
EV / FCF
|
15
x
|
12.8
x
|
3.81
x
|
6.4
x
|
19.4
x
|
5.58
x
|
FCF Yield
|
6.66%
|
7.8%
|
26.2%
|
15.6%
|
5.15%
|
17.9%
|
Price to Book
|
0.5
x
|
0.49
x
|
0.38
x
|
0.45
x
|
0.8
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
1,536,662
|
1,536,662
|
1,531,503
|
1,531,503
|
1,554,851
|
1,554,851
|
Reference price
2 |
615.0
|
610.0
|
490.0
|
715.0
|
1,390
|
1,305
|
Announcement Date
|
3/29/19
|
4/2/20
|
5/6/21
|
3/31/22
|
4/11/23
|
3/14/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,076,493
|
6,534,734
|
5,592,338
|
6,635,544
|
7,879,115
|
7,316,902
|
EBITDA
1 |
627,076
|
576,863
|
545,585
|
683,268
|
737,691
|
490,326
|
EBIT
1 |
466,027
|
423,607
|
402,129
|
551,381
|
570,910
|
353,269
|
Operating Margin
|
6.59%
|
6.48%
|
7.19%
|
8.31%
|
7.25%
|
4.83%
|
Earnings before Tax (EBT)
1 |
308,160
|
304,273
|
197,745
|
440,608
|
440,630
|
233,840
|
Net income
1 |
200,336
|
180,563
|
75,218
|
279,627
|
321,012
|
160,943
|
Net margin
|
2.83%
|
2.76%
|
1.35%
|
4.21%
|
4.07%
|
2.2%
|
EPS
2 |
131.3
|
117.5
|
48.89
|
182.0
|
206.5
|
103.8
|
Free Cash Flow
1 |
223,925
|
236,344
|
610,353
|
366,036
|
169,568
|
480,339
|
FCF margin
|
3.16%
|
3.62%
|
10.91%
|
5.52%
|
2.15%
|
6.56%
|
FCF Conversion (EBITDA)
|
35.71%
|
40.97%
|
111.87%
|
53.57%
|
22.99%
|
97.96%
|
FCF Conversion (Net income)
|
111.77%
|
130.89%
|
811.45%
|
130.9%
|
52.82%
|
298.45%
|
Dividend per Share
|
-
|
35.00
|
15.00
|
70.00
|
75.00
|
-
|
Announcement Date
|
3/29/19
|
4/2/20
|
5/6/21
|
3/31/22
|
4/11/23
|
3/14/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,415,969
|
2,090,807
|
1,577,754
|
1,247,332
|
1,130,316
|
651,274
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.853
x
|
3.624
x
|
2.892
x
|
1.826
x
|
1.532
x
|
1.328
x
|
Free Cash Flow
1 |
223,925
|
236,344
|
610,353
|
366,036
|
169,569
|
480,339
|
ROE (net income / shareholders' equity)
|
11.7%
|
10.5%
|
5.37%
|
12.6%
|
11.9%
|
5.62%
|
ROA (Net income/ Total Assets)
|
4.82%
|
4.35%
|
4.41%
|
5.87%
|
5.8%
|
3.77%
|
Assets
1 |
4,157,125
|
4,154,025
|
1,704,039
|
4,767,317
|
5,538,318
|
4,272,558
|
Book Value Per Share
2 |
1,225
|
1,253
|
1,301
|
1,575
|
1,741
|
1,768
|
Cash Flow per Share
2 |
93.40
|
56.10
|
246.0
|
321.0
|
153.0
|
249.0
|
Capex
1 |
124,213
|
173,268
|
154,265
|
79,957
|
74,107
|
62,065
|
Capex / Sales
|
1.76%
|
2.65%
|
2.76%
|
1.2%
|
0.94%
|
0.85%
|
Announcement Date
|
3/29/19
|
4/2/20
|
5/6/21
|
3/31/22
|
4/11/23
|
3/14/24
|
|
1st Jan change
|
Capi.
|
---|
| -23.37% | 92.31M | | +13.35% | 83.58B | | -10.18% | 42.51B | | +6.86% | 33.53B | | +16.94% | 19.3B | | +11.53% | 11.48B | | -12.85% | 9.28B | | +0.48% | 9.26B | | -3.49% | 8.51B | | +5.37% | 8.33B |
Diversified Chemicals
|